                         SEQUENCE LISTING

<110>  BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
 
<120>  COMBINATION OF EZH2 INHIBITOR AND CHECKPOINT THERAPY FOR THE 
       TREATMENT OF CANCER

<130>  UTFC.P1337WO

<150>  US 62/685,239
<151>  2018-06-14

<160>  6     

<170>  PatentIn version 3.5

<210>  1
<211>  23
<212>  DNA
<213>  Artificial sequence

<220>
<223>  Synthetic primer

<400>  1
cattgctgac aggatgcaga agg                                               23


<210>  2
<211>  22
<212>  DNA
<213>  Artificial sequence

<220>
<223>  Synthetic primer

<400>  2
tgctggaagg tggacagtga gg                                                22


<210>  3
<211>  24
<212>  DNA
<213>  Artificial sequence

<220>
<223>  Synthetic primer

<400>  3
cctagtgata aggaatgcac gatg                                              24


<210>  4
<211>  23
<212>  DNA
<213>  Artificial sequence

<220>
<223>  Synthetic primer

<400>  4
ctaggcaggt ttgatctccg ttc                                               23


<210>  5
<211>  22
<212>  DNA
<213>  Artificial sequence

<220>
<223>  Synthetic primer

<400>  5
atcatccctg cgagcctatc ct                                                22


<210>  6
<211>  24
<212>  DNA
<213>  Artificial sequence

<220>
<223>  Synthetic primer

<400>  6
gacctttttt ggctaaacgc tttc                                              24


